These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34988039)

  • 1. Timely Recognition and Early Multi-Step Antinflammatory Therapy May Prevent ICU Admission of Patients With MIS-C: Proposal for a Severity Score.
    Brisca G; Consolaro A; Caorsi R; Pirlo D; Tuo G; Campanello C; Castagnola E; Moscatelli A; Gattorno M; Ravelli A
    Front Pediatr; 2021; 9():783745. PubMed ID: 34988039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
    Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
    Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning from the COVID-19 pandemic: IMCU as a more efficient model of pediatric critical care organization.
    Brisca G; Tardini G; Pirlo D; Romanengo M; Buffoni I; Mallamaci M; Carrato V; Lionetti B; Molteni M; Castagnola E; Moscatelli A
    Am J Emerg Med; 2023 Feb; 64():169-173. PubMed ID: 36563501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early is superior to late plasma exchange for severe multisystem inflammatory syndrome in children.
    Katlan B; Kesici S; Karacanoğlu D; Oygar PD; Ünal Yüksekgönül A; Şener S; Aykan HH; Özsurekçi Y; Özen S; Bayrakci B
    J Clin Apher; 2022 Jun; 37(3):281-291. PubMed ID: 35174897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
    Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F;
    JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome.
    Buda P; Strauss E; Januszkiewicz-Lewandowska D; Czerwinska E; Ludwikowska K; Szenborn L; Gowin E; Okarska-Napierała M; Kuchar E; Ksia Zyk J
    Front Pediatr; 2022; 10():981711. PubMed ID: 36186637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
    Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
    García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
    Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicolaboratory Profile, Treatment, Intensive Care Needs, and Outcome of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: A Systematic Review and Meta-analysis.
    Williams V; Dash N; Suthar R; Mohandoss V; Jaiswal N; Kavitha TK; Nallasamy K; Angurana SK
    J Pediatr Intensive Care; 2022 Mar; 11(1):1-12. PubMed ID: 35178272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity.
    Taddio A; Della Paolera S; Abbagnato L; Agrusti A; Badolato R; Biscaro F; Caorsi R; Consolaro A; Dellepiane RM; Fabi M; Floretta I; Gattorno M; Giangreco M; La Torre F; Maggio MC; Mambelli L; Mauro A; Mastrolia MV; Meneghel A; Montin D; Ricci F; Simonini G; Smarrazzo A; Sottile R; Stucchi S; Tardi M; Verdoni L; Zuccotti G; Zunica F; Ravelli A; Cattalini M;
    Rheumatology (Oxford); 2024 Feb; 63(2):366-375. PubMed ID: 37647645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland.
    Fouriki A; Fougère Y; De Camaret C; Blanchard Rohner G; Grazioli S; Wagner N; Relly C; Pachlopnik Schmid J; Trück J; Kottanatu L; Perez E; Perez MH; Schaffner D; Asner SA; Hofer M
    Front Pediatr; 2020; 8():594127. PubMed ID: 33469522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Treatments for Multisystem Inflammatory Syndrome in Children (MIS-C), United States, February 2020 - July 2021.
    Abrams JY; Belay ED; Godfred-Cato S; Campbell AP; Zambrano LD; Kunkel A; Miller AD; Wu MJ; Meng L; Shah AB; Oster ME
    Clin Infect Dis; 2022 Sep; 75(7):1201-1209. PubMed ID: 35100610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-month follow-up of patients with covid-19 temporally related multi-system inflammatory syndrome in children: the experience of the children hospital of Palermo.
    Maggio MC; Giordano S; Failla MC; Campione MG; Alaimo A; Corsello G
    Ital J Pediatr; 2023 Mar; 49(1):37. PubMed ID: 36959663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center.
    Sözeri B; Çağlayan Ş; Atasayan V; Ulu K; Coşkuner T; Pelin Akbay Ö; Hasbal Akkuş C; Atay G; Salı E; Karacan M; Öner T; Erdoğan S; Demir F
    Postgrad Med; 2021 Nov; 133(8):994-1000. PubMed ID: 34605352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinico-Laboratory Profile, Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience during First and Second Waves from North India.
    Angurana SK; Kumar V; Nallasamy K; Kumar MR; Naganur S; Kumar M; Goyal K; Ghosh A; Bansal A; Jayashree M
    J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36048462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicolored MIS-C, a single-centre cohort study.
    Varga P; Balajthy A; Biró E; Bíró B; Reiger Z; Szikszay E; Mogyorósy G; Káposzta R; Szabó T
    BMC Pediatr; 2023 Apr; 23(1):190. PubMed ID: 37085781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection: a Systematic Review with Meta-analysis.
    Sood M; Sharma S; Sood I; Sharma K; Kaushik A
    SN Compr Clin Med; 2021; 3(1):38-47. PubMed ID: 33432304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study.
    Licciardi F; Covizzi C; Dellepiane M; Olivini N; Mastrolia MV; Lo Vecchio A; Monno V; Tardi M; Mauro A; Alessio M; Filocamo G; Cattalini M; Taddio A; Caorsi R; Marseglia GL; La Torre F; Campana A; Simonini G; Ravelli A; Montin D
    Front Pediatr; 2023; 11():1137051. PubMed ID: 37675397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.